253 related articles for article (PubMed ID: 22147246)
1. Association between red cell distribution width and disease activity in patients with inflammatory bowel disease.
Song CS; Park DI; Yoon MY; Seok HS; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI
Dig Dis Sci; 2012 Apr; 57(4):1033-8. PubMed ID: 22147246
[TBL] [Abstract][Full Text] [Related]
2. Red cell distribution width for assessment of activity of inflammatory bowel disease.
Cakal B; Akoz AG; Ustundag Y; Yalinkilic M; Ulker A; Ankarali H
Dig Dis Sci; 2009 Apr; 54(4):842-7. PubMed ID: 18716874
[TBL] [Abstract][Full Text] [Related]
3. Association between thrombocytosis and iron deficiency anemia in inflammatory bowel disease.
Voudoukis E; Karmiris K; Oustamanolakis P; Theodoropoulou A; Sfiridaki A; Paspatis GA; Koutroubakis IE
Eur J Gastroenterol Hepatol; 2013 Oct; 25(10):1212-6. PubMed ID: 23839158
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
5. [Inflammatory bowel disease in children--an analysis of the clinical symptoms and selected biochemical parameters].
Landowski P; Liberek A; Szlagatys-Sidorkiewicz A; Radys W; Brodzicki J; Szarszewski A; Marek A; Łuczak G; Kamińska B
Med Wieku Rozwoj; 2007; 11(4):401-7. PubMed ID: 18605192
[TBL] [Abstract][Full Text] [Related]
6. The use of serum calprotectin as a biomarker for inflammatory activity in inflammatory bowel disease.
Suárez Ferrer C; Abadía Barno M; Martín Arranz E; Jochems A; García Ramírez L; Poza Cordón J; Jaquotot Herranz M; Cerpa Arencibia A; Martín Arranz MD
Rev Esp Enferm Dig; 2019 Oct; 111(10):744-749. PubMed ID: 31476872
[TBL] [Abstract][Full Text] [Related]
7. Value of red cell distribution width for assessing disease activity in Crohn's disease.
Hu D; Ren J; Wang G; Gu G; Li G; Liu S; Wu X; Chen J; Wu Q; Ren H; Hong Z; Li J
Am J Med Sci; 2015 Jan; 349(1):42-5. PubMed ID: 25171547
[TBL] [Abstract][Full Text] [Related]
8. Impaired erythrocyte antioxidant defense in active inflammatory bowel disease: impact of anemia and treatment.
Krzystek-Korpacka M; Neubauer K; Berdowska I; Zielinski B; Paradowski L; Gamian A
Inflamm Bowel Dis; 2010 Sep; 16(9):1467-75. PubMed ID: 20186929
[TBL] [Abstract][Full Text] [Related]
9. Increased circulating circular RNA_103516 is a novel biomarker for inflammatory bowel disease in adult patients.
Ye YL; Yin J; Hu T; Zhang LP; Wu LY; Pang Z
World J Gastroenterol; 2019 Nov; 25(41):6273-6288. PubMed ID: 31749597
[TBL] [Abstract][Full Text] [Related]
10. Red cell distribution width: a novel marker of activity in inflammatory bowel disease.
Yeşil A; Senateş E; Bayoğlu IV; Erdem ED; Demirtunç R; Kurdaş Övünç AO
Gut Liver; 2011 Dec; 5(4):460-7. PubMed ID: 22195244
[TBL] [Abstract][Full Text] [Related]
11. Combined Use of Common Fecal and Blood Markers for Detection of Endoscopically Active Inflammatory Bowel Disease.
Mak LY; Tong TSM; Cheung KS; Chen LJ; Lui KL; Lau KS; Leung WK
Clin Transl Gastroenterol; 2020 Mar; 11(3):e00138. PubMed ID: 32132451
[TBL] [Abstract][Full Text] [Related]
12. Growth differentiation factor-15 serum concentrations reflect disease severity and anemia in patients with inflammatory bowel disease.
Tonkic A; Kumric M; Akrapovic Olic I; Rusic D; Zivkovic PM; Supe Domic D; Sundov Z; Males I; Bozic J
World J Gastroenterol; 2024 Apr; 30(13):1899-1910. PubMed ID: 38659482
[TBL] [Abstract][Full Text] [Related]
13. Impaired coronary microvascular and left ventricular diastolic function in patients with inflammatory bowel disease.
Caliskan Z; Gokturk HS; Caliskan M; Gullu H; Ciftci O; Ozgur GT; Guven A; Selcuk H
Microvasc Res; 2015 Jan; 97():25-30. PubMed ID: 25128749
[TBL] [Abstract][Full Text] [Related]
14. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
[TBL] [Abstract][Full Text] [Related]
15. Five-Year Period Prevalence and Characteristics of Anemia in a Large US Inflammatory Bowel Disease Cohort.
Koutroubakis IE; Ramos-Rivers C; Regueiro M; Koutroumpakis E; Click B; Schwartz M; Swoger J; Baidoo L; Hashash JG; Barrie A; Dunn MA; Binion DG
J Clin Gastroenterol; 2016 Sep; 50(8):638-43. PubMed ID: 26485103
[TBL] [Abstract][Full Text] [Related]
16. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
[TBL] [Abstract][Full Text] [Related]
17. Correlation between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease.
Xu M; Cen M; Chen X; Chen H; Liu X; Cao Q
Biomed Res Int; 2019; 2019():6517549. PubMed ID: 31950048
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of the highly sensitive C-reactive protein/albumin ratio to determine disease activity in inflammatory bowel disease.
Liu A; Lv H; Tan B; Shu H; Yang H; Li J; Qian J
Medicine (Baltimore); 2021 Apr; 100(14):e25200. PubMed ID: 33832080
[TBL] [Abstract][Full Text] [Related]
19. Measurement of reticulocyte and red blood cell indices in the evaluation of anemia in inflammatory bowel disease.
Oustamanolakis P; Koutroubakis IE; Messaritakis I; Kefalogiannis G; Niniraki M; Kouroumalis EA
J Crohns Colitis; 2011 Aug; 5(4):295-300. PubMed ID: 21683299
[TBL] [Abstract][Full Text] [Related]
20. Serum galectins as potential biomarkers of inflammatory bowel diseases.
Yu TB; Dodd S; Yu LG; Subramanian S
PLoS One; 2020; 15(1):e0227306. PubMed ID: 31929564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
